167 related articles for article (PubMed ID: 33592583)
1. Expression and prognostic values of ARID family members in breast cancer.
Zhang J; Hou S; You Z; Li G; Xu S; Li X; Zhang X; Lei B; Pang D
Aging (Albany NY); 2021 Feb; 13(4):5621-5637. PubMed ID: 33592583
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Landscape of ARID Family Members and Their Association with Prognosis and Tumor Microenvironment in Hepatocellular Carcinoma.
Sun J; Cheng NS
J Immunol Res; 2022; 2022():1688460. PubMed ID: 35402625
[TBL] [Abstract][Full Text] [Related]
3. Distinct prognostic values of S100 mRNA expression in breast cancer.
Zhang S; Wang Z; Liu W; Lei R; Shan J; Li L; Wang X
Sci Rep; 2017 Jan; 7():39786. PubMed ID: 28051137
[TBL] [Abstract][Full Text] [Related]
4. The Prognostic Value of AT-Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma.
Li S; Wu Z; Li Q; Liang Q; Zhou H; Shi Y; Zhang R; Pan H
Evid Based Complement Alternat Med; 2022; 2022():1150390. PubMed ID: 36034939
[TBL] [Abstract][Full Text] [Related]
5. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
6. Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer.
Zhang Y; Yu C
BMC Cancer; 2020 Jun; 20(1):575. PubMed ID: 32560641
[TBL] [Abstract][Full Text] [Related]
7. The histone chaperone HJURP is a new independent prognostic marker for luminal A breast carcinoma.
Montes de Oca R; Gurard-Levin ZA; Berger F; Rehman H; Martel E; Corpet A; de Koning L; Vassias I; Wilson LO; Meseure D; Reyal F; Savignoni A; Asselain B; Sastre-Garau X; Almouzni G
Mol Oncol; 2015 Mar; 9(3):657-74. PubMed ID: 25497280
[TBL] [Abstract][Full Text] [Related]
8. Expression of Protein 4.1 Family in Breast Cancer: Database Mining for 4.1 Family Members in Malignancies.
Feng G; Guo K; Yan Q; Ye Y; Shen M; Ruan S; Qiu S
Med Sci Monit; 2019 May; 25():3374-3389. PubMed ID: 31063460
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.
Liang YK; Han ZD; Lu JM; Liu ZZ; Zhuo YJ; Zhu XJ; Chen JX; Ye JH; Liang YX; He HC; Zhong WD
J Cell Biochem; 2018 Sep; 119(9):7245-7255. PubMed ID: 29797600
[TBL] [Abstract][Full Text] [Related]
10. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
[TBL] [Abstract][Full Text] [Related]
11. Frequent low expression of chromatin remodeling gene ARID1A in breast cancer and its clinical significance.
Zhang X; Zhang Y; Yang Y; Niu M; Sun S; Ji H; Ma Y; Yao G; Jiang Y; Shan M; Zhang G; Pang D
Cancer Epidemiol; 2012 Jun; 36(3):288-93. PubMed ID: 21889920
[TBL] [Abstract][Full Text] [Related]
12. SYCP2 expression is a novel prognostic biomarker in luminal A/B breast cancer.
Wu C; Tuo Y
Future Oncol; 2019 Mar; 15(8):817-826. PubMed ID: 30511892
[TBL] [Abstract][Full Text] [Related]
13. Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.
Zhou XL; Zeng D; Ye YH; Sun SM; Lu XF; Liang WQ; Chen CF; Lin HY
Oncol Rep; 2018 Oct; 40(4):1897-1906. PubMed ID: 30066902
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
[TBL] [Abstract][Full Text] [Related]
15. The prognostic value of Piezo1 in breast cancer patients with various clinicopathological features.
Xu H; Chen Z; Li C
Anticancer Drugs; 2021 Apr; 32(4):448-455. PubMed ID: 33559992
[TBL] [Abstract][Full Text] [Related]
16. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
[TBL] [Abstract][Full Text] [Related]
18. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
Wang X; Zhang T; Zhang S; Shan J
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
[No Abstract] [Full Text] [Related]
19. Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patients.
Ankney JA; Xie L; Wrobel JA; Wang L; Chen X
BMC Med Genomics; 2019 May; 12(1):78. PubMed ID: 31146747
[TBL] [Abstract][Full Text] [Related]
20. The prognostic values of insulin-like growth factor binding protein in breast cancer.
Wang J; Luo XX; Tang YL; Xu JX; Zeng ZG
Medicine (Baltimore); 2019 May; 98(19):e15561. PubMed ID: 31083221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]